This message was sent to ##Email##
|
| October 15, 2015 |
| |  | | |
|
|
|
ITNS
There’s still time to submit an abstract for the 25th Annual ITNS Symposium! The deadline has been extended until Midnight ET on Monday, Oct. 26. Don’t miss your chance! View the submission requirements and submit an abstract.
When: Tuesday Oct. 20, 2015
Where: Bertucci’s Restaurant, 4054 Mystic Valley Parkway, Medford, MA 02155
Time: 7:00 p.m.
Pre-Registration Price: $20.00
Door Price: $25.00
To register: Please send RSVP to
NewEnglandITNS@gmail.com
Focus Information Agency
"Insufficient number of donors is not only a Bulgarian problem, but it is a global problem." That is what Prof. Dr. Gencho Nachev, director of St Ekaterina University Hospital for Active Treatment, said in an interview for FOCUS News Agency.
"Around 56,000 people in Europe need transplantation of organs or tissues," Prof. Nachev said.
He specified that organ donation rate is a country depends on the organization. According to him, first there must be nationwide awareness campaign which to explain people what does organ donation mean, how complex the transplantation surgery is and what follows afterwards.
READ MORE
Oncology Nurse Advisor
Bone marrow transplantation is a life-saving treatment for many people with blood cancers such as leukemia and lymphomas.
The gold standard for treatment is to obtain blood-generating stem cells from a sibling who is a perfect match to the recipient, to minimize potential for graft rejection; however, not all patients will have a full-match sibling. A potential resolution is to use half-match donors, who are relatives but may not be a sibling.
READ MORE
WFAA-TV
In a country where five million people have heart disease, getting a heart transplant is a big deal.
Only about 2,300 patients undergo the procedure. Darrell Horton was one of them.
He got a new heart in August. About two months later, he went back for a special doctor's appointment. From Henderson, Texas in Rusk County, Horton, his wife Sam and the new heart inside his chest traveled back to Baylor University Medical Center in Dallas.
READ MORE
EurekAlert!
Patients with Light-chain (AL) amyloidosis who are treated with high-dose chemotherapy (melphalan) and autologous (one's own) stem cell transplantation (HDM/SCT) have the greatest success for long-term survival.
These findings, which appear as a "Letter" in the journal Blood, (Journal of the American Society of Hematology), report on the largest number of patients in the world receiving high dose chemotherapy and stem cell transplantation for this rare disease.
READ MORE
WTAE-TV
A retired Pittsburgh police officer feels like he won the lottery. But the prize is not money. It is a chance to participate in a medical device trial.
Connie Foltyn, 68, has heart failure after suffering three heart attacks. He was being considered as a candidate for a heart transplant or an artificial pump.
“There were times when if I wanted to get up from the couch in the living room and walk to the kitchen I'd have to stop two, three times to catch my breath,” Foltyn said.
Then, last October, doctors at Allegheny Health Network’s Cardiovascular Institute told him he was a perfect candidate for a cardiac parachute.
READ MORE
PR Newswire
CareDx, Inc., a molecular diagnostics company, called for a reversal of a recent proposal by the Centers for Medicare & Medicaid Services (CMS) to drastically reduce reimbursement for its FDA-cleared diagnostic test AlloMap, which measures gene expression levels to help clinicians determine a heart transplant recipient's risk for organ rejection.
READ MORE
The Telegraph
Pig organs could soon be transplanted into patients after Harvard University scientists discovered a way to genetically modify pig DNA so it is more compatible with humans.
Scientists have spent decades trying to engineer pig tissue so that it would not be rejected by the human body, but the immune system has always prevented success.
All pig DNA carries the porcine endogenous retrovirus which infects human cells and makes transplantation impossible. Now Professor George Church and colleagues have used a ground-breaking technology called Crispr to snip away the retrovirus' genetic code.
READ MORE
NYC City News
The biggest study ever of women who have their ovarian tissue removed has found cryopreservation and transplantation of ovarian tissue in female cancer survivors is safe and effective when it comes to keeping fertility intact.
In the procedure, doctors remove one ovary and cut into strips and freeze them. When the women recover from cancer, doctors graft some of the thawed-out tissue on the remaining ovary.
READ MORE
Healio
Preliminary clinical data showed brincidofovir reduced adenovirus infection viral load among adult and pediatric liver transplant recipients post-transplant, according to a poster presentation at IDWeek 2015. Researchers, including Diana F. Florescu, M.D., associate professor, Internal Medicine Division of Infectious Disease, University of Nebraska Medical Center, Omaha, evaluated 13 liver transplant recipients with adenovirus (AdV) infection following LT alone or as part of a multi-organ transplantation, identified from two studies known as the AdVise trial. Of these patients, 10 pediatric and three adult, all underwent treatment with brincidofovir (Chimerix) for a median of 79 days and were assessed for changes in AdV viral load from baseline, time to nadir viral load, survival and adverse events.
READ MORE
Triangle Business Journal
Duke Medicine launched a hand transplant program, the first in North Carolina.
The Duke program is part of a clinical trial to determine the safety and efficacy of hand transplantation for patients who have lost one or both limbs below the elbow. The trial will also test the effectiveness of a new drug, belatacept, in preventing rejection of the transplanted hand.
READ MORE
Renal & Urology News
Late-onset BK virus nephopathy (BKVN) in kidney transplant recipients is associated with less adherence to screening guidelines for the virus compared with early-onset BKVN, investigators reported at ID Week.
The finding implies that late-onset BKVN represents progression of undiagnosed earlier-onset BK virus infection, concluded Kathryn Whitaker, M.D., and colleagues at the University of Washington in Seattle.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
